199 related articles for article (PubMed ID: 33313141)
1.
Cheng H; Wu X; Ni G; Wang S; Peng W; Zhang H; Gao J; Li X
Ann Transl Med; 2020 Nov; 8(21):1396. PubMed ID: 33313141
[TBL] [Abstract][Full Text] [Related]
2.
Ni G; Wang K; Zhou Y; Wu X; Wang J; Shang H; Wang L; Li X
Ann Transl Med; 2020 Sep; 8(17):1064. PubMed ID: 33145283
[TBL] [Abstract][Full Text] [Related]
3. Traditional Chinese medicine Qiliqiangxin attenuates phenylephrine-induced cardiac hypertrophy via upregulating PPARγ and PGC-1α.
Gao RR; Wu XD; Jiang HM; Zhu YJ; Zhou YL; Zhang HF; Yao WM; Li YQ; Li XL
Ann Transl Med; 2018 Apr; 6(8):153. PubMed ID: 29862242
[TBL] [Abstract][Full Text] [Related]
4. Citri Reticulatae Pericarpium alleviates postmyocardial infarction heart failure by upregulating PPARγ expression.
Chen M; Zhu H; Zhu Q; Wu X; Zhou Y; Gao R; Shi M; Zhang T; Yin T; Zhang H; Shang H; Li X
Clin Exp Pharmacol Physiol; 2022 Jun; 49(6):661-673. PubMed ID: 35278230
[TBL] [Abstract][Full Text] [Related]
5. Traditional Chinese Medication Qiliqiangxin Attenuates Diabetic Cardiomyopathy via Activating PPARγ.
Wu X; Zhang T; Lyu P; Chen M; Ni G; Cheng H; Xu G; Li X; Wang L; Shang H
Front Cardiovasc Med; 2021; 8():698056. PubMed ID: 34336956
[No Abstract] [Full Text] [Related]
6. Nobiletin Attenuates Pathological Cardiac Remodeling after Myocardial Infarction via Activating PPAR
Zhou Y; Yin T; Shi M; Chen M; Wu X; Wang K; Cheang I; Li Y; Shang H; Zhang H; Li X
PPAR Res; 2021; 2021():9947656. PubMed ID: 34422028
[TBL] [Abstract][Full Text] [Related]
7. Qiliqiangxin Attenuates Adverse Cardiac Remodeling after Myocardial Infarction in Ovariectomized Mice via Activation of PPARγ.
Shen S; Jiang H; Bei Y; Zhang J; Zhang H; Zhu H; Zhang C; Yao W; Wei C; Shang H; Li X
Cell Physiol Biochem; 2017; 42(3):876-888. PubMed ID: 28647730
[TBL] [Abstract][Full Text] [Related]
8. Traditional Chinese Medication Qiliqiangxin Protects Against Cardiac Remodeling and Dysfunction in Spontaneously Hypertensive Rats.
Wang H; Zhang X; Yu P; Zhou Q; Zhang J; Zhang H; Zhu H; Zhang C; Yao W; Che L; Xu J; Bei Y; Li X
Int J Med Sci; 2017; 14(5):506-514. PubMed ID: 28539827
[TBL] [Abstract][Full Text] [Related]
9. Qiliqiangxin attenuates isoproterenol-induced cardiac remodeling in mice.
Zhang J; Huang M; Shen S; Wu X; Wu X; Lv P; Zhang H; Wang H; Li X
Am J Transl Res; 2017; 9(12):5585-5593. PubMed ID: 29312510
[TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
[TBL] [Abstract][Full Text] [Related]
11. Astragalus polysaccharide attenuates isoproterenol-induced cardiac hypertrophy by regulating TNF-α/PGC-1α signaling mediated energy biosynthesis.
Luan A; Tang F; Yang Y; Lu M; Wang H; Zhang Y
Environ Toxicol Pharmacol; 2015 May; 39(3):1081-90. PubMed ID: 25880160
[TBL] [Abstract][Full Text] [Related]
12. AdipoRon prevents l-thyroxine or isoproterenol-induced cardiac hypertrophy through regulating the AMPK-related pathway.
Hu X; Ou-Yang Q; Wang L; Li T; Xie X; Liu J
Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):20-30. PubMed ID: 30566571
[TBL] [Abstract][Full Text] [Related]
13. Plantago asiatica L. seeds extract protects against cardiomyocyte injury in isoproterenol- induced cardiac hypertrophy by inhibiting excessive autophagy and apoptosis in mice.
Fan W; Zhang B; Wu C; Wu H; Wu J; Wu S; Zhang J; Yang X; Yang L; Hu Z; Wu X
Phytomedicine; 2021 Oct; 91():153681. PubMed ID: 34371252
[TBL] [Abstract][Full Text] [Related]
14. Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice.
Tao L; Shen S; Fu S; Fang H; Wang X; Das S; Sluijter JP; Rosenzweig A; Zhou Y; Kong X; Xiao J; Li X
Sci Rep; 2015 Feb; 5():8374. PubMed ID: 25669146
[TBL] [Abstract][Full Text] [Related]
15. Dissection of mechanisms of Chinese medicinal formula Si-Miao-Yong-an decoction protects against cardiac hypertrophy and fibrosis in isoprenaline-induced heart failure.
Zhao Y; Jiang Y; Chen Y; Zhang F; Zhang X; Zhu L; Yao X
J Ethnopharmacol; 2020 Feb; 248():112050. PubMed ID: 31265887
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
Tan X; Li J; Wang X; Chen N; Cai B; Wang G; Shan H; Dong D; Liu Y; Li X; Yang F; Li X; Zhang P; Li X; Yang B; Lu Y
Int J Biol Sci; 2011 Apr; 7(3):383-9. PubMed ID: 21494433
[TBL] [Abstract][Full Text] [Related]
17. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
[TBL] [Abstract][Full Text] [Related]
19. Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway.
Shang L; Pin L; Zhu S; Zhong X; Zhang Y; Shun M; Liu Y; Hou M
Chem Biol Interact; 2019 Jul; 307():21-28. PubMed ID: 31009642
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-9 Aggravates Isoproterenol-Induced Heart Failure by Activating Signal Transducer and Activator of Transcription 3 Signalling.
Yang Y; Xu C; Tang S; Xia Z
Can J Cardiol; 2020 Nov; 36(11):1770-1781. PubMed ID: 32621886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
